Importantly, inhibition of CSF1R signaling can reprogram immunosuppressive TAM responses and generate anti-tumor responses in multiple mouse tumor models [33–35], and a similar approach in the RENCA model may yield similar results. Here, CSF1R is linked to neoplasm.